French pharmaceutical company buys Meriden-based Protein Sciences

MERIDEN, Conn. (WTNH) — A French pharmaceutical company is buying Meriden-based Protein Sciences.

Sanofi made the announcement on Tuesday that it is paying up to $750 million for the privately held vaccines biotech company.

Protein Sciences produces Flublok, the only non-egg based flu vaccine approved by the FDA.

Manon Cox, who heads up Protein Sciences, says the company was looking for an opportunity to grow more of its business.

WTNH NEWS8 provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review. Also, you can now block any inappropriate user by simple selecting the drop down menu on the right of any comment and selection "Block User" from there.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s